Kayne Anderson Rudnick Investment Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $278K | Buy |
714
+9
| +1% | +$3.5K | ﹤0.01% | 477 |
|
|
2025
Q1 | $307K | Hold |
705
| – | – | ﹤0.01% | 450 |
|
|
2024
Q4 | $260K | Sell |
705
-4
| -0.6% | -$1.48K | ﹤0.01% | 441 |
|
|
2024
Q3 | $369K | Buy |
709
+4
| +0.6% | +$2.08K | ﹤0.01% | 415 |
|
|
2024
Q2 | $382K | Buy |
705
+3
| +0.4% | +$1.63K | ﹤0.01% | 428 |
|
|
2024
Q1 | $364K | Hold |
702
| – | – | ﹤0.01% | 430 |
|
|
2023
Q4 | $331K | Buy |
702
+4
| +0.6% | +$1.89K | ﹤0.01% | 405 |
|
|
2023
Q3 | $304K | Hold |
698
| – | – | ﹤0.01% | 409 |
|
|
2023
Q2 | $310K | Buy |
698
+4
| +0.6% | +$1.78K | ﹤0.01% | 408 |
|
|
2023
Q1 | $319K | Hold |
694
| – | – | ﹤0.01% | 396 |
|
|
2022
Q4 | $356K | Hold |
694
| – | – | ﹤0.01% | 401 |
|
|
2022
Q3 | $315K | Buy |
694
+3
| +0.4% | +$1.36K | ﹤0.01% | 391 |
|
|
2022
Q2 | $333K | Sell |
691
-11
| -2% | -$5.3K | ﹤0.01% | 388 |
|
|
2022
Q1 | $345K | Buy |
702
+8
| +1% | +$3.93K | ﹤0.01% | 380 |
|
|
2021
Q4 | $322K | Buy |
694
+3
| +0.4% | +$1.39K | ﹤0.01% | 390 |
|
|
2021
Q3 | $258K | Hold |
691
| – | – | ﹤0.01% | 389 |
|
|
2021
Q2 | $264K | Hold |
691
| – | – | ﹤0.01% | 386 |
|
|
2021
Q1 | $248K | Hold |
691
| – | – | ﹤0.01% | 386 |
|
|
2020
Q4 | $222K | Hold |
691
| – | – | ﹤0.01% | 376 |
|
|
2020
Q3 | $186K | Sell |
691
-25
| -3% | -$6.73K | ﹤0.01% | 374 |
|
|
2020
Q2 | $188K | Hold |
716
| – | – | ﹤0.01% | 361 |
|
|
2020
Q1 | $163K | Sell |
716
-3
| -0.4% | -$683 | ﹤0.01% | 354 |
|
|
2019
Q4 | $217K | Buy |
719
+3
| +0.4% | +$905 | ﹤0.01% | 347 |
|
|
2019
Q3 | $172K | Buy |
716
+691
| +2,764% | +$166K | ﹤0.01% | 347 |
|
|
2019
Q2 | $7K | Buy |
+25
| New | +$7K | ﹤0.01% | 415 |
|